Status:

COMPLETED

Prospective Observational Pilot-study for the Evaluation of the Nephro- an Neurotoxicity in the Anti-infectious Therapy With Inhalative Colistin Therapy for Patients With Ventilator-associated Pneumonia (VAP)

Lead Sponsor:

Charite University, Berlin, Germany

Conditions:

Infection Resistant to Multiple Drugs

Eligibility:

All Genders

18+ years

Brief Summary

Multi-Drug resistant pathogens (MDR) are reported worldwide with increasing incidence, especially in intensive care settings. One of the drugs which are effective against MDRs, is colistin (polymyxin...

Detailed Description

There is growing evidence that patients in the ICU setting have a special risk profile for consecutive colonization and possible infection due to MDR pathogens. One therapy option is the use of inhal...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • invasive ventilated patients (male and female) with assumed or assured bacteria with an elevated resistance pattern found in a tracheal or bronchial secretion with or without clinical signs of infection
  • indicated colistin co-therapy or eradication-attempt with inhalative colistin (β-Lactam) therapy according to the standard operation procedure (SOP) of the hospital
  • Exclusion criteria:
  • Consent of the patient or of the patient´s legal representative can´t be obtained soon
  • Age \< 18 years
  • Included within another, prospective clinical antibiotics-study
  • Hypersensitivity to colistin or polymyxin B
  • Patients with cystic fibrosis
  • Present letter of attorney or patient´s provision, which precludes a priori the participation in studies
  • Missing consent for storage of pseudonymised data in context of the study
  • The patient is in an institution due to a court injunction or administrative order

Exclusion

    Key Trial Info

    Start Date :

    September 1 2013

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2015

    Estimated Enrollment :

    9 Patients enrolled

    Trial Details

    Trial ID

    NCT01894347

    Start Date

    September 1 2013

    End Date

    December 1 2015

    Last Update

    August 3 2016

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Charité Universitätsmedizin Charité

    Berlin, State of Berlin, Germany, 13353